DysUFMylation reprograms immunosuppressive neutrophils to potentiate anti-PD-1 therapy in hepatocellular carcinoma. - Gao X; Xu M; Han Z; Hu Z; Su Y; Sun G; Chen W; Qiu S; Hung MC; Zhou C; Yi Y (Cancer letters, 2026)